Cytek Biosciences, Inc. (NASDAQ: CTKB - Get Free Report) reached a new 52-week high during mid-day t

Bank of America Corp DE purchased a new position in shares of Cytek Biosciences, Inc. (NASDAQ: CTKB)

Cytek has expanded its Cytek® Cloud digital ecosystem with a new Cloud Analysis tool to create the i

Revvity (NYSE: RVTY - Get Free Report) and Cytek Biosciences (NASDAQ: CTKB - Get Free Report) are bo

Investors need to pay close attention to CTKB stock based on the movements in the options market lat

Cytek Biosciences, Inc. (CTKB) Presents at Morgan Stanley 24th Annual Global Healthcare Conference T

FREMONT, Calif., and HAMBURG, Germany, Sept.

FREMONT, Calif., Sept. 03, 2026 (GLOBE NEWSWIRE) -- As clinical laboratories seek deeper cellular in

Deutsche Bank AG bought a new position in Cytek Biosciences, Inc. (NASDAQ: CTKB) in the undefined qu

FREMONT, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leadin

Cytek Biosciences, Inc. ("Cytek Biosciences," "Cytek," or the "Company") (NA

FREMONT, Calif., Aug. 21, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences,” “Cy

Cytek Biosciences, Inc. (CTKB) Q2 2026 Earnings Call Transcript

Cytek Biosciences NASDAQ: CTKB reported second-quarter 2026 revenue growth of 6% year over year, sup

Cytek Biosciences, Inc. (CTKB) came out with a quarterly loss of $0.05 per share versus the Zacks Co

Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.09) per share which met the analyst

Cytek Biosciences (NASDAQ:CTKB) raises FY2026 sales outlook from $205.000 million-$212.000 million t

FREMONT, Calif., Aug. 05, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “

Cytek Biosciences (CTKB) doesn't possess the right combination of the two key ingredients for a like

Champions Oncology and Cytek Biosciences have different growth drivers and valuations, but which lif

FREMONT, Calif., July 22, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (“Cytek Biosciences” or “

US stock futures higher with Nasdaq 100 up 150 points. Ryanair (RYAAY) shares fall after weak Q1 res

FREMONT, Calif., July 15, 2026 (GLOBE NEWSWIRE) -- Spectral flow cytometry leader Cytek Biosciences,

FREMONT, Calif., June 10, 2026 (GLOBE NEWSWIRE) -- Cytek Biosciences, Inc. (Nasdaq: CTKB), a leading

US stock futures higher, Nasdaq futures down. Concrete Pumping Holdings shares up 28.94% pre-market.

US stock futures lower, Braze Inc (BRZE) shares drop 8.4% in pre-market trading after reporting mixe

Phreesia (NYSE: PHR) shares rose in pre-market trading after better-than-expected sales results. Oth

Stephens & Co. analyst Mason Carrico maintains Cytek Biosciences (NASDAQ:CTKB) with a Overwei

Morgan Stanley analyst Tejas Savant maintains Cytek Biosciences (NASDAQ:CTKB) with a Equal-Weight

Cytek Biosciences (NASDAQ:CTKB) affirms FY2026 sales outlook from $205.000 million-$212.000 million

Cytek Biosciences (NASDAQ:CTKB) reported quarterly losses of $(0.15) per share which missed the anal

U.S. stocks were lower, with the Dow Jones index falling around 80 points on Monday.

Shares of Butterfly Network, Inc. (NASDAQ: BFLY) fell sharply during Thursday’s session after the

Companies Reporting Before The Bell • ICL Group (NYSE:ICL) is likely to report quarterly earnings a

Companies Reporting Before The Bell • CorEnergy Infr Tr (NYSE:CORR) is estimated to report earnings